In AML patients, the positive expression rate of CD7 is approximately 30% (16–18), but the prognostic significance of its expression has been inconsistently reported (17, 19–23), and further analysis and subgroup evaluation are needed. Here, CD7 is linked to acute myeloid leukemia.